Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Company details
Scottish National Blood Transfusion Services
Delivering Transfusion Medicine needs for patients in Scotland.The company in detail
Profile
SNBTS, the specialist provider of transfusion medicine in Scotland, provides a comprehensive range of blood components, clinical services and human tissue for patient care. Collaborations with more than fifty organisations in over 20 countries including universities, pharmaceutical and diagnostic industries and national transfusion services to improve patient care and research into new blood products and treatments using considerable scientific and clinical expertise. Services: wide range of clinical and diagnostic services in field of transfusion medicine. Nucleic acid testing, micro-assay technologies, specialised monoclonal antibodies, prion removal and inactivation, ex vivo cellular manipulation, cell culture, gene therapy, molecular biology, immunoassay.
Partnering strategy/interests
SNBTS is divesting its human plasma fractionation business and therfore has a variety of patented technologies available for sale or licence. Many of these also have utility in the wider biologics manufacturing industry.
Out-licensing
Use of depth filters to remove prion infectivity from plasma - derived therapeutic products and/or other biologics. Depth Filtration is a chemically inactive process and therefore does not introduce potentially toxic bi-products or alter components. More
Proprietary process to produce a freeze-dried fibrinogen therapeutic product, easily soluble. Includes two virus inactivation processes: dry heat treatment and solvent/detergent. More
Proprietary manufacturing process for a liquid IVIgG product - in great demand world-wide as one of the principal therapeutics obtained from blood plasma. Process delivers a low IgA content, which increases renal tolerability. More
Proprietary process for removing adsorbed prion infectivity from reusable substrates such as chromatography columns used for example in processing blood plasma into therapeutic products and other biologics. More
There are a number of proprietary technologies used to achieve low aluminium levels in biologicals stored in glass bottles. This particular technology provides an alternative to licensing in and/or risk of infringement of 3rd party technologies. More
Novel process for production of thrombin and thrombin preparations capable of being produced in a freeze dried form, which may be heat-treated to inactivate any viruses present. More
UV based method and apparatus for inactivating microorganisms in biologics without adversely affecting biological activity. More
The invention teaches a step - charge in yielding improvement over the Cohn process, widely applicable to immunoglobulin manufacture. More
Head office
Scottish National Blood Transfusion Services
21 Ellen's Glen Road
Edinburgh
Scotland
EH17 7QT
United Kingdom
Tel: 0131 536 5976
Fax: 0131 536 5956
www | email
21 Ellen's Glen Road
Edinburgh
Scotland
EH17 7QT
United Kingdom
Tel: 0131 536 5976
Fax: 0131 536 5956
www | email
Contact details
Ian Hardie
Business Development Manager
Business Development Manager
Company figures
Formed: 1940
Annual Turnover: £>€1m
Annual Turnover: £>€1m
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us